111111111111111111111111111111111111111111111111111111111111111111111111111111111
The selection process for the position of Egis Group’s Commercial Director has been closed. As a result, dr Csaba Pácz remains head of the Commercial Directorate.
The predecessor of Egis Pharmaceuticals PLC, Dr Wander Pharmaceuticals and Nutriments Ltd. was registered on 19 February 1913.
Csaba Poroszlai is confirmed CEO of the company by the Board of Directors of Egis. Balázs Vándor is appointed to the position of the Company’s Chief Financial Officer.
Since the very beginning of the war in Ukraine, Egis Pharmaceuticals PLC has been committed to helping and supporting those in need in all possible ways.
Egis has been present in Ukraine for more than 20 years – its representative office has become an important player for supplying the country with medicines since its opening in 1999. Egis helps its colleagues in Ukraine in every way it can and provides humanitarian aid to Ukrainian patients in the current situation.
Standing together has never been so crucial for the Egis family than in these difficult times.
Two technology-intensive developments, carried out with state subsidies, were completed at Egis Pharmaceuticals PLC’s Körmend site (Hungary). The investments were inaugurated by Péter Szijjártó, Minister of Foreign Affairs and Trade, and by the company’s CEO, Dr. István Hodász on 15 October. In addition to a new packaging plant, Egis has also established a plant with special knowledge and technology requirements, typically suitable to manufacture oncology products. Thus, Egis is now able to implement all value-creating processes within the field of oncology, from development to active ingredient and finished product manufacturing.
We have commemorated World Cancer Day.
Egis today is among the Top50 foreign companies operating in Vietnam.
The performance of the Hungarian pharmaceutical industry in the last ‘peaceful year’ before the coronavirus epidemic was reviewed in a comprehensive analysis by Nézőpont Institute on behalf of 16 pharmaceutical companies of the Hungarian Pharmaceutical Manufacturers Association (MAGYOSZ).
Disinfection plays an important role in reducing the risk of infection. As a responsible company, Egis supports the safe operation of pharmacies in the second wave of the coronavirus pandemic as well.